Drug Discovery informatics Market (By Function: Target Identification & Validation, Lead Generation, Molecular Modeling, Libraries and Database Preparation, Others; By Solution: Software and Services; By Application: Drug Discovery and Drug Development; By End-use: Pharma & Biotech Research Organizations and Contract Research Organizations (CROs)) Market - Growth, Future Prospects, Post COVID-19 Scenario 2020 - 2028

Drug discovery informatics offers better solutions to researchers by escalating the speed of drug discovery, drug development, clinical studies, etc. where a large number of data is generated throughout the process. Drug discovery informatics does not only help to speed up the process but also increases the accuracy by shortening the buffer time in research. With the current COVID-19 pandemic conditions, the demand for drug discovery informatics has increased at a significant rate. The instant need for vaccines due to the lethal nature of COVID-19 infection is forcing many pharma and biotech players to focus on the development of vaccines and other similar drugs. To conduct drug discovery in a short period, leading biological companies and contract research organizations are taking assistance of drug discovery informatics.
 
Major functions of drug discovery informatics include target identification & validation, lead generation, molecular modeling, libraries and database preparation, among others. The solutions provided by drug discovery informatics are in the form of software and services. Drug discovery informatics adopted by the end-user such as pharma & biotech research organizations and contract research organization (CRO) assist in the drug discovery and drug development applications. With the higher chances of progression in chronic diseases in the following years, the use of drug discovery informatics by pharma and biotech as well CROs is anticipated to upsurge at a significant rate. Early drug discovery is also important for pharma and biological players to stay ahead in the market.

 
Competitive nature of the global drug discovery informatics market forcing leading players to stay updated with the market trends and advanced technologies. As the demand for drug discovery informatics has been increasing from the CROs sector, market players are bound to provide advanced technologies. Major players operating in the global drug discovery informatics market include Certara, L.P., Infosys Limited, IBM Corporation, PerkinElmer, Inc., Schrodinger, Inc., Collaborative Drug Discovery, Inc., Jubilant Life Sciences Ltd., Thermo Fisher Scientific, Inc., Charles River Systems, Inc., Novo Informatics Pvt. Ltd. among others.



Global Drug Discovery Informatics Market, By Function

Based on the function, the global drug discovery informatics market is bifurcated into the following

Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2019 and 2028:


In 2019, target identification and validation was the largest segment by function in terms of market share. The segment held about 30% of the share in the global market. Demand for new drug discovery for chronic diseases is on rise, which in turn increasing the demand of new target identification & validation. Identifying new drug target through compound libraries for drug discoveries augmenting the need of informatics.

Global Drug Discovery Informatics Market, By Solution

Based on the solution the global drug discovery informatics market is bifurcated into the following

Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2019 and 2028:
 

In 2019, the demand for drug discovery informatics software was observed to be high. The software sub segment clearly dominated the solution segment and grabbed around 65% share of the overall market. The services segment on other hand is anticipated to register rapid growth over the forecast period.

Global Drug Discovery Informatics Market, By Application

Based on the application the global drug discovery informatics market is bifurcated into the following

Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2019 and 2028:


The demand of drug discovery informatics was observed high for drug discovery in the year 2019. The high demand was attributed by growing research on new drug discoveries all over the world. Since 2020, the ongoing pandemic situation has also caused a shift in the focus towards effective drug development for chronic diseases. The drug discovery segment held around 51% share of the market in 2019. However, the demand for drug development application is expected to grow at a significant rate in the following years.

Global Drug Discovery Informatics Market, By End User

Based on the end user, the global drug discovery informatics market is bifurcated into the following

Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2019 and 2028:


In 2019, the contract research organizations (CROs) segment held major share of the overall drug discovery informatics market. The segment clearly shown its dominance by securing the market. This segment held around 64% share of the overall market and expected to register a significant growth over the forecast period.
 
Global Drug Discovery Informatics Market, By Geography

Based on geography, the drug discovery informatics market is segmented into following:

Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2019 and 2028:


 In 2019, North America held the largest share in the drug discovery informatics market due presence of major pharma and biotech players, and rapid growth in drug discovery research. However, due to low research cost, growing demand of new drug discoveries, and presence of large number of CROs in developing countries such as China and India, Asia Pacific region is experiencing rapid surge in drug discovery contracts from across the world. Significant rise in drug discovery projects is augmenting the rapid growth of the drug discovery informatics market in the region.